136 related articles for article (PubMed ID: 33395752)
1. Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation.
Hodkinson BP; Schaffer M; Brody JD; Jurczak W; Carpio C; Ben-Yehuda D; Avivi I; Forslund A; Özcan M; Alvarez J; Ceulemans R; Fourneau N; Younes A; Balasubramanian S
Transl Oncol; 2021 Jan; 14(1):100977. PubMed ID: 33395752
[TBL] [Abstract][Full Text] [Related]
2. Expression of "DNA damage response" pathway genes in diffuse large B-cell lymphoma: The potential for exploiting synthetic lethality.
Mansoor A; Kamran H; Rizwan H; Akhter A; Roshan TM; Shabani-Rad MT; Bavi P; Stewart D
Hematol Oncol; 2024 Jan; 42(1):e3225. PubMed ID: 37795760
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.
Arzuaga-Mendez J; Lopez-Santillan M; Garcia-Ruiz JC; Lopez-Lopez E; Martin-Guerrero I
Crit Rev Oncol Hematol; 2021 Mar; 159():103247. PubMed ID: 33515703
[TBL] [Abstract][Full Text] [Related]
4. Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention.
Dobaño-López C; Araujo-Ayala F; Serrat N; Valero JG; Pérez-Galán P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562694
[TBL] [Abstract][Full Text] [Related]
5. Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Bolen CR; Mattiello F; Herold M; Hiddemann W; Huet S; Klapper W; Marcus R; Mir F; Salles G; Weigert O; Nielsen T; Oestergaard MZ; Venstrom JM
Blood; 2021 May; 137(19):2704-2707. PubMed ID: 33512481
[No Abstract] [Full Text] [Related]
6. Radiotherapy for early and advanced stages Follicular Lymphoma.
Mauro GP; Medici CTM; Casimiro LC; Weltman E
Clinics (Sao Paulo); 2021; 76():e2059. PubMed ID: 33503179
[TBL] [Abstract][Full Text] [Related]
7. PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
Beck Enemark M; Monrad I; Madsen C; Lystlund Lauridsen K; Honoré B; Plesner TL; Hamilton-Dutoit SJ; d'Amore F; Ludvigsen M
Onco Targets Ther; 2021; 14():481-489. PubMed ID: 33500624
[TBL] [Abstract][Full Text] [Related]
8. A Moving Target: Inactivating BTK Mutations as Drivers of Follicular Lymphoma.
Afaghani J; Taylor J
Clin Cancer Res; 2021 Apr; 27(8):2123-2125. PubMed ID: 33579791
[TBL] [Abstract][Full Text] [Related]
9. Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis.
Duś-Szachniewicz K; Rymkiewicz G; Agrawal AK; Kołodziej P; Wiśniewski JR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562532
[TBL] [Abstract][Full Text] [Related]
10. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract][Full Text] [Related]
11. Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months.
Rajamäki A; Sunela K; Prusila REI; Kuusisto MEL; Mercadal S; Selander T; Kuitunen H; Pollari M; Jantunen E; Nystrand I; Sancho JM; Sorigue M; Kuittinen O
Leuk Lymphoma; 2021 Jul; 62(7):1639-1647. PubMed ID: 33546574
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 inhibition in DLBCL: "the times they are a-changing"?
Vitolo U; Novo M
Blood; 2021 Feb; 137(5):577-579. PubMed ID: 33538802
[No Abstract] [Full Text] [Related]
13. Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Joffe E; Leyfman Y; Drill E; Rajeeve S; Zelenetz AD; Palomba ML; Moskowitz CH; Portlock C; Noy A; Horwitz SM; Gerecitano JF; Moskowitz A; Hamlin P; Matasar MJ; Kumar A; Batlevi CL; Younes A; Straus DJ
Blood Adv; 2021 Jan; 5(2):345-351. PubMed ID: 33496731
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
Jain P; Kanagal-Shamanna R; Zhang S; Ok CY; Navsaria L; Nastoupil L; Lee HJ; Tang G; Yin CC; Badillo M; Nair R; Li S; Patel KM; Flowers C; Vega F; Wang L; Wang ML
Am J Hematol; 2021 May; 96(5):E137-E140. PubMed ID: 33491779
[No Abstract] [Full Text] [Related]
15. Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis.
Smith SD; Lopedote P; Samara Y; Mei M; Herrera AF; Winter AM; Hill BT; Shadman M; Ujjani C; Lynch RC; Jacobson CA; Kim AI; Caimi P; Milano F; Gopal AK
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):170-175. PubMed ID: 33431309
[TBL] [Abstract][Full Text] [Related]
16. Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation.
Hu N; Wang F; Sun T; Xu Z; Zhang J; Bernard D; Xu S; Wang S; Kaminski M; Devata S; Phillips T; Malek SN
Clin Cancer Res; 2021 Apr; 27(8):2301-2313. PubMed ID: 33419778
[TBL] [Abstract][Full Text] [Related]
17. How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
Lumish M; Falchi L; Imber BS; Scordo M; von Keudell G; Joffe E
J Hematol Oncol; 2021 Jan; 14(1):5. PubMed ID: 33407745
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
Balasubramanian S; Wang S; Major C; Hodkinson B; Schaffer M; Sehn LH; Johnson P; Zinzani PL; Carey J; Shreeve SM; Sun S; Gerecitano J; Vermeulen J; Staudt LM; Wilson W
Br J Haematol; 2021 Jul; 194(1):83-91. PubMed ID: 33942292
[TBL] [Abstract][Full Text] [Related]
19. Targeted Treatment of Follicular Lymphoma.
Nath K; Gandhi MK
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33671658
[TBL] [Abstract][Full Text] [Related]
20. HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.
Golkaram M; Salmans ML; Kaplan S; Vijayaraghavan R; Martins M; Khan N; Garbutt C; Wise A; Yao J; Casimiro S; Abreu C; Macedo D; Costa AL; Alvim C; Mansinho A; Filipe P; Marques da Costa P; Fernandes A; Borralho P; Ferreira C; Aldeia F; Malaquias J; Godsey J; So A; Pawlowski T; Costa L; Zhang S; Liu L
NPJ Genom Med; 2021 Feb; 6(1):13. PubMed ID: 33589643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
